HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therap
Miguel Ángel Artacho1, Pablo Barreiro2, José Vicente Fernández-Mont...
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and gainst HIV: e...
Full list of author information is available at the end of the articleIntroduction With the advent o...
Introduction Telmisartan, an angiotensin receptor blocker, has beneficial effects on insulin resista...
Introduction Telmisartan, an angiotensin receptor blocker, has beneficial effects on insulin resista...
Background Combination antiretroviral therapy results in metabolic abnormalities which increase card...
BackgroundCombination antiretroviral therapy (cART) is the standard for human immunodeficiency virus...
Background: Hypertension is more prevalent among HIV- infected individuals than in the general popul...
Background: Antiretroviral therapy in HIV-positive patients leads to insulin resistance which is ce...
Visceral adiposity in the setting of HIV infection and antiretroviral therapy (ART) is not fully und...
The increase in incidence of HIV infection continues to be a major public health problem across the ...
Visceral adiposity in the setting of HIV infection and antiretroviral therapy (ART) is not fully und...
Hypertension can be managed effectively with a wide range of drugs from different classes. However, ...
BACKGROUND:Currently recommended boosted protease-inhibitor (bPI) regimens may be associated with in...
Objectives: The use of tenofovir is highly associated with the emergence of mutation K65R, which con...
Miguel Ángel Artacho1, Pablo Barreiro2, José Vicente Fernández-Mont...
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and gainst HIV: e...
Full list of author information is available at the end of the articleIntroduction With the advent o...
Introduction Telmisartan, an angiotensin receptor blocker, has beneficial effects on insulin resista...
Introduction Telmisartan, an angiotensin receptor blocker, has beneficial effects on insulin resista...
Background Combination antiretroviral therapy results in metabolic abnormalities which increase card...
BackgroundCombination antiretroviral therapy (cART) is the standard for human immunodeficiency virus...
Background: Hypertension is more prevalent among HIV- infected individuals than in the general popul...
Background: Antiretroviral therapy in HIV-positive patients leads to insulin resistance which is ce...
Visceral adiposity in the setting of HIV infection and antiretroviral therapy (ART) is not fully und...
The increase in incidence of HIV infection continues to be a major public health problem across the ...
Visceral adiposity in the setting of HIV infection and antiretroviral therapy (ART) is not fully und...
Hypertension can be managed effectively with a wide range of drugs from different classes. However, ...
BACKGROUND:Currently recommended boosted protease-inhibitor (bPI) regimens may be associated with in...
Objectives: The use of tenofovir is highly associated with the emergence of mutation K65R, which con...
Miguel Ángel Artacho1, Pablo Barreiro2, José Vicente Fernández-Mont...
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and gainst HIV: e...
Full list of author information is available at the end of the articleIntroduction With the advent o...